APA (7th ed.) Citation

S, E., Z, X., AJ, L., M, D., K, E., E, L., . . . SF, W. (2022). Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data. Multiple sclerosis and related disorders, 57, 103433. https://doi.org/10.1016/j.msard.2021.103433

Chicago Style (17th ed.) Citation

S, Epstein, et al. "Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data." Multiple Sclerosis and Related Disorders 57 (2022): 103433. https://doi.org/10.1016/j.msard.2021.103433.

MLA (9th ed.) Citation

S, Epstein, et al. "Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data." Multiple Sclerosis and Related Disorders, vol. 57, 2022, p. 103433, https://doi.org/10.1016/j.msard.2021.103433.